In analyzing the forecast for Genitourinary System Diseases mortality in the US, standardized rates for female deaths per hundred thousand women show stability with slight increases over the upcoming years. From 2024 to 2028, the mortality rate is predicted to hold steady at 21.0 per 100,000 women until a minor rise to 21.1 is observed from 2026 onwards. In 2023, the standardized mortality rate stood slightly below the forecasted 2024 figure, highlighting marginal growth in mortality.
Future trends to watch for include the impact of healthcare innovations, changes in public health policies, and demographic shifts, which might influence these standardized mortality rates. Additionally, increased awareness and early detection initiatives may contribute to improved outcomes.